Mary C Squire Dds Pc | |
3429 Richville Rd Manchester Ct VT 05255 | |
(802) 366-9119 | |
(802) 366-9099 |
Full Name | Mary C Squire Dds Pc |
---|---|
Speciality | Dentist |
Location | 3429 Richville Rd, Manchester Ct, Vermont |
Authorized Official Name and Position | Mary C Squire (PRESIDENT) |
Authorized Official Contact | 8023669119 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Mary C Squire Dds Pc Po Box 1724 Manchester Center VT 05255 Ph: (802) 366-9119 | Mary C Squire Dds Pc 3429 Richville Rd Manchester Ct VT 05255 Ph: (802) 366-9119 |
NPI Number | 1285858068 |
---|---|
Provider Enumeration Date | 04/12/2007 |
Last Update Date | 08/22/2020 |
Identifier | Type | State | Issuer |
---|---|---|---|
1285858068 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | 1079 (Vermont) | Primary |
122300000X | Dentist | 041234 (New York) | Secondary |
News Archive
The National Institutes of Health (NIH) will hold a State-of-the-Science Conference on Management of Menopause-Related Symptoms, March 21-23, 2005, at the Natcher Conference Center on the NIH campus in Bethesda, Maryland.
Studies of the spinal fluid of patients given anti-HIV drugs have resulted in new findings suggesting that the brain can act as a hiding place for the HIV virus. Around 10% of patients showed traces of the virus in their spinal fluid but not in their blood.
A soft pillow and a warm duvet are all you need to have a soothing and relaxing sleep, especially during the frigid season. However, a man from the United Kingdom nearly died because of a mysterious illness related to a duvet. It was later found out by doctors that the culprit for his lung disease is his newly-bought feather duvet.
Oncolytics Biotech Inc. today announced that enrollment has been completed in a randomized Phase II study of REOLYSIN in patients with previously treated advanced or metastatic non-small cell lung cancer ("NSCLC") (IND 211). The trial is being sponsored and conducted by the NCIC Clinical Trials Group (NCIC CTG) at Queen's University in Kingston, Ontario.
The University of North Carolina at Chapel Hill has been awarded a five-year, $6.2 million renewal grant to continue its work as part of the National Institutes of Health's Rare Diseases Clinical Research Network (RDCRN).
› Verified 2 days ago